Phenomenex’s Post

📌 We are excited to attend the LSX World Congress USA 2024 in Boston, USA, on September 11-12, 2024. Meet Nhakulan Dhamodharan and Shilpi Priyadarshini at the Congress to discuss how Syngene can help you accelerate your drug discovery programs.   To book a meeting with our experts, visit the link in the comments section.   Our capabilities include: ⦿ Antibody Discovery & Development ⦿ Extensive In-Vitro & In-Vivo Biological Assay Capability ⦿ Cell Line Development & Analysis ⦿ CAR-T Therapy Research ⦿ Therapeutic Clone Development & Manufacturing ⦿ Critical Reagent generation and assay development ⦿ Large-scale protein expression (Bacterial, Insect, Pichia and Mammalian) and more... #LSX2024 #DiscoveryServices #Syngene

𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗭𝗧 𝗦𝗰𝗮𝗻 𝗗𝗜𝗔 𝗳𝗼𝗿 𝗾𝘂𝗮𝗻𝘁𝗶𝘁𝗮𝘁𝗶𝘃𝗲 𝗽𝗿𝗼𝘁𝗲𝗼𝗺𝗶𝗰𝘀! ZT Scan DIA combines the depth of data independent acquisition (DIA) method with the precision of targeted approaches, delivering precise quantitative outcomes at up to ten times the speed of conventional DIA methods. Make crucial therapeutic pathway decisions with confidence. Discover how ZT Scan DIA bridges the gap between identification and translation, allowing you to better understand disease states and the efficacy of precision therapeutics. Visit our website to learn more about this innovative solution and stay ahead of the next (r)evolution in #DIA-based mass spectrometry 👉 https://sciex.li/3u76dc Learn more about this news in Technology Networks 👉 https://bit.ly/3Rn46CJ #DanaherNews #Proteomics #BiomarkerResearch #ZTScanDIA #QuantitativeAnalysis #MassSpec #ZenoRevolution

Elevate your biomarker research with our advanced #proteomics services leveraging Olink Proteomics technology, performed in compliance with GcLP guidelines. As one of the select Contract Research Organizations (CROs) actively validating Good Clinical Laboratory Practice (GcLP) operations on Olink® Target 48 and Flex panels, we uphold the highest quality standards. The Olink® Target 48 panel accelerates targeted protein #biomarker discovery, enabling faster and more informed decisions. The customizable Olink® Flex panel allows the selection and combination of up to 21 human proteins into one biomarker panel and can be paired with our newly-acquired Olink® Signature Q100 instrument. We ensure reliability, accuracy and speed when providing our protein biomarker analysis services. https://lnkd.in/eHqjcRAz #Multiomics #BioanalyticalLaboratory #Partnership #Innovation #BiomarkerDiscovery

For decades, the complexity of plasma has limited its accessibility in proteomics. Even today, plasma proteomics can be costly, complex, irreproducible, and time consuming. Our solution? The ENRICH-iST kit, designed to provide an easy-to-use, robust solution to the dynamic range problem. Join product developer Xaver as he delves into how the all-in-one plasma and serum preparation solution works to enrich low abundant proteins onto paramagnetic beads, making it suitable for a range of applications, including biomarker and drug discovery. 📺 Watch the video: https://ow.ly/sfJx50TGtrz #plasmaprep #serumprep #samplepreparation #proteomics #ENRICHiST #LCMS #MassSpec #drugdiscovery

Expand mass spectrometry-based proteomics into preclinical and clinical drug development. In this exceptional work by Andrew Chambers, Yeoun Jin Kim, Steve Sweet, Zifeng Song, Philip Martin, Matthew Ellis, Claire Rooney, and David Chain, the team was able to demonstrate a FAIMS-PRM assay for direct quantification of free RASG12C in FFPE tissue samples without the requirement for protein enrichment or isolation. Benefits included: - reduced sample input requirement - streamlined workflow enabling high-throughput analysis - ability to multiplex additional protein targets. Their analytical tool of choice?... The Evosep One coupled to an Orbitrap Fusion Lumos mass spectrometer with FAIMS-PRO interface. Read the full manuscript in the journal of clinical proteomics by clicking on this link https://lnkd.in/gYDKbKs3 To learn more about the Evosep One platform, visit our website evosep.com or reach out to me for a discussion. #evosep #orbitrap #massspectrometry #proteomics

NEWS RELEASE WRN degradation and efficacy test, alone with WRNi HRO-761 resistant cell line generation. Happy to share our WRN cell panel list with proteomics and RNAseq analysis for drug discovery program. Freel free to reach out more screening assays for WRN and DDR targets. #WRN #Degradation #ResistantCellLine #Screening #ICEBioscience #CellPanel #Proteomics #RNAseq

Curious about how to link cytokine secretion to killing activity or gene expression of T cells? Wondering how to measure if a specific IFNɣ-secreting cell can kill targets—and how many? Have precious clinical samples and need precise answers? With Beacon Platform, we tackle these complex questions and more. If you're asking these questions, it’s time to explore how our platform can provide the insights you need. Get in touch with us today to learn more! https://hubs.ly/Q02NgCMV0

Helix's CEO, Josh Carter, is participating at the American Crystallographic Association's 74th Annual Meeting in Denver, Colorado, from July 7-12, 2024. Day 4 has been filled with valuable networking opportunities and insightful presentations in areas such as protein flexibility and drug design, data analysis for structural elucidation, and MicroED for small molecules. Two fantastic presentations included “Structure Determination of Difficult to Grow Active Pharmaceutical Ingredients (APIs) using MicroED” by AbbVie, and “Structure determination by NMR Crystallography, from microcrystalline powders to amorphous molecular solids” by EPFL (Switzerland). And the poster sessions also continue to showcase groundbreaking research! If you are at the conference, Josh would be delighted to connect, discuss science, and exchange insights. He looks forward to sharing how his and Helix's expertise excels in overcoming challenges and advancing projects. Did you know that our Cryo-EM and X-ray services can help you gain unprecedented insights into the structural details of your biological entity of interest, whether wild-type or mutated? Call us today and get the peace of mind you deserve! (https://loom.ly/S6ImyLI) #cryoem #crystallization #crystallography #drugdiscovery #drugdesign #protein #proteins #dna #rna #antibody #antibodies #science #nature #research #bio #bionetwork #biotechnology #biotech #bioscience #biotechnologyindustry #biopharma #drugdesign #drugdevelopment #pharmaceuticals #pharma #drug #lifesciences #lifescience

“It’s important to know exactly what proteins do, how they behave, how they change, where the pockets are that small molecules can influence their capabilities. That’s why proteomics is essentially the bread and butter of the pharmacology industry.” -Bogdan Budnik, Wyss Principal Scientist Learn more from Bogdan about proteomics and its potential for impact in the pharma industry and personalized medicine in this piece from PharmaVoice. #Proteomics #Impact #Pharmaceuticals #Pharmacology #PersonalizedMedicine https://lnkd.in/ePVzb5qh

So amazing how fast antibody production can be! As their catch phrase goes, Biointron can certainly help with accelerating your antibody discovery. https://lnkd.in/gbgdjSYe